Background: Epidermal growth factor receptor (EGFR) activation is important in human epithelial malignancies, including cutaneous squamous cell carcinoma, lung, colon, pancreatic, and other cancers. Therapies targeting EGFR are currently used to treat such cancers, but one significant drawback to EGFR inhibitor therapies is the associated skin toxicity. This toxicity usually presents as papular or pustular folliculitis, dry skin with pruritus and hair and nail abnormalities. The side effects often limit the usefulness of EGFR inhibitors in cancer treatment. The transcriptional changes caused by EGFR inhibition in epidermal keratinocytes have not been extensively explored. Methods: To define the transcriptional changes caused by inhibition of EGFR in primary human epidermal keratinocytes, these cells were treated with Tyrphostin AG1478 and treated and control cultures were compared in parallel, using Affymetrix microarrays. Using meta analysis approaches, the observed changes were integrated with a large set of already existing data on transcriptional profiling in epidermal keratinocytes. Results: We found that at the early time points, 1 hour and 4 hours after addition, AG1478 suppresses expression of genes associated with keratinocyte proliferation, attachment and motility. Apoptosis is facilitated by both induction of proapoptotic and suppression of antiapoptotic genes. Angiogenesis signals are suppressed as well. At late time points, 24 hours and 48 hours, EGFR inhibition induces mitochondrial activity and suppresses splicing and protein trafficking. Certain transcriptional effects of EGFR inhibition go against the transcriptional effects of retinoids. Surprisingly, at 48 hours, EGFR inhi bition induces expression of markers of epidermal differentiation. Conclusion: Our results define the role of EGF receptor in human keratinocytes and the consequences of its inhibition.
Introduction
Among the first signaling molecules isolated, epidermal growth factor (EGF) was named for its capacity to accelerate epidermal differentiation, as measured by the eye opening in newborn mice. 1 Since then, EGF and its receptor (EGFR) have become possibly the most studied models of extracellular and intracellular signaling mechanisms. 2 5 The binding of EGF to its receptor causes the receptor to dimerize and consequently activate its cytoplasmic kinase. 6 The activated kinase phosphorylates several substrates which, when phosphorylated, transmit cytoplasmic signals to the nucleus by activating transcription factors that regulate expression of many genes. 7 In general, the EGF regulated genes promote cell proliferation and survival, inhibit apoptosis, support chemotactic migration, while suppressing terminal differentiation. 8 Several ligands in addition to EGF bind and cause activation of EGFR, e.g., tumor growth factor a (TGFa), and heparin binding EGF. 9 EGFR is closely related to the ErbB family of protein kinases. 10 EGFR is very important in healthy epidermal homeostasis and disruption of the EGFR signaling has been demonstrated in several skin diseases. 11 In epidermis, EGFR activation contributes to wound healing, regulates barrier function, suppresses terminal differenti ation, causes loss of adhesion, induces secreted proteases, etc. 11, 12 Furthermore, EGFR is often over expressed in cutaneous squa mous cell carcinomas. 13 EGFR activation is a feature of numerous human epithelial malignancies, including cancers of the colon, head and neck, lung, and pancreas. 8 Therefore, therapies targeting EGFR by small molecules or antibodies became a paradigm for treatment of human cancers. 3 Detailed molecular understanding of the kinase domain led to development of specific inhibitors, gefitinib, erloti nib, Herceptin (trastuzumab), cetuximab, currently used to treat breast, lung, ovarian, prostate, head and neck, and other cancers. 8, 14 These drugs induce tumor regressions proving the importance of the EGFR signals in some cancers. EGFR targeted treatments avoid the adverse effects commonly encountered with chemotherapy, such as nausea, vomiting or hematological toxicities. However, there are two significant drawbacks to EGFR inhibitor therapies: (1) the intrinsic and acquired resistance to treatment; and (2) the associated skin toxicity. 15, 16 The cutaneous reactions to these treatments usually present as papular or pustular folliculitis erup tions. Later manifestations include generalized dry skin, pruritus, and hair and nail abnormalities. 17 These side effects often limit the duration or dosage of EGFR inhibitors in cancer treatment. Given the importance of cutaneous manifestations of EGFR targeted therapies, it is surprising that the transcriptional changes caused by the EGFR inhibition have not been extensively explored in epidermal keratinocytes. To define the transcriptional changes caused by inhibition of EGFR in primary human epidermal kerati nocytes, we treated these cells with Tyrphostin AG1478, a specific inhibitor of the EGFR kinase domain, and compared parallel treated and control cultures using Affymetrix microarrays. We used publi cally available, free meta analysis programs to integrate the observed changes with a large set of already existing data on transcriptional profiling in epidermal keratinocytes. 18 23 We found that Tyrphostin AG1478 inhibits expression of genes associated with keratinocyte proliferation, attachment and motility and, surpris ingly, induces expression of markers of epidermal differentiation.
Materials and methods

Human keratinocyte cultures
The growth and treatment of normal human neonatal foreskin epidermal keratinocytes has been described. 18, 24, 25 Briefly, keratinocytes were obtained from Dr. M. Simon (Living Skin Bank, Burn Unit SUNY, Stony Brook, NY, USA) and grown in a defined serum free keratinocyte growth medium (keratino cyte SFM; Gibco, Grand Island, NY, USA) supplemented with 2.5 ng/mL epidermal growth factor, 0.05 mg/mL bovine pitui tary extract, and 1% penicillin/streptomycin at 37 C in 5% CO 2 . Third passage cells were used at 70e80% confluency. Kerati nocytes, grown on 100 mm plates, were then treated with 1mM Tyrphostin AG1478 (Sigma Aldrich, St Louis, MO, USA). The cells were harvested by scraping 1 hour, 4 hours, 24 hours and 48 hours after treatment.
Preparation of labeled cRNA and GeneChip hybridization
Total RNA was isolated from treated and untreated keratinocytes with RNeasy kits (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. Approximately 5 mg of total RNA was reverse transcribed, amplified, and labeled as described previ ously. 26, 27 A 15 mg sample of labeled cRNA was fragmented and hybridized to HU133Av2 arrays (Affymetrix, Santa Clara, CA, USA). The arrays were washed, stained with anti biotin streptavidin phycoerythrin labeled antibody, and scanned using the Agilent GeneArray scanner system (Hewlett Packard, Palo Alto, CA, USA) and GeneChip 3.0 software (Affymetrix) to determine the expres sion of each gene.
Array data analysis
Generally, the same data analysis approach as described previously was used. 24 Intensity values from the chips were obtained using Microarray Suite v. 5.0 (Affymetrix), and scaled by calculating the overall signal for each array. To compare data from multiple arrays, the signal of each probe array was scaled to the same target intensity value of 500 arbitrary units. RMAExpress was used for background adjustment, quintile normalization, summarization, and quality analysis. RMAExpress is a program that computes gene expression summary values and performs quality assessment for Affymetrix data using the Robust Multichip Average protocol. 28 Raw data CEL files have been deposited in the Gene Expression Omnibus (GEO) database and are available with the accession number GSE41680. Regulated genes were selected as differentially expressed 50% or more between the Tyrphostin AG1478 treated and the control samples at the same time point. The hierarchical clustering was performed using TIGR MultiExperiment Viewer algorithms. 29 Annotation and ontology of regulated genes was ob tained using Database for Annotation, Visualization and Integrated Discovery (DAVID). 30, 31 Transcription factor binding sites were also evaluated using DAVID, in a separate analysis. In addition, lists of Affymetrix IDs of regulated genes were submitted to DAVID.
30
DAVID provided 'tables' containing functional and ontological details of the regulated genes, 'charts' containing ontological cate gories, pathways etc., over represented in the gene lists, 'clusters' of such ontological categories (which identified redundancies and overlaps), transcription factors over represented in the promoters of the genes, as well as sub lists of genes specific for each onto logical category. From the 'tables', lists of consensus gene symbols were re formatted, and submitted to the List2Networks program 32 . This allowed identification of specific functional commonalities in various lists of genes, providing the meta analysis results.
Meta-analysis comparisons of regulated genes in keratinocytes
In our previous studies we defined the genes regulated in kerati nocytes by interferon g (IFNg), interleukin 1 (IL 1), retinoic acid (RA), EphrinA proteins, and JNK inhibitor SP600125. 18, 19, 21, 23, 25 Using DAVID, the lists of official symbols of regulated genes in those studies were collected, as were those of the Tyrphostin AG1478 regulated genes from this study, and these were then submitted to the List2 Network analysis program. 32 The program compares lists for mutual overlaps within specific categories, e.g., targets of protein kinases, ontological biological process, or OMIM disease gene association, returning statistical evaluation of the overlaps. When seven different relevant categories were analyzed, it was found that 'Gene Ontology Biological Process' is the most informative, probably because it is the best annotated and most complete. The matrices of p values of gene lists overlaps were downloaded, along with spreadsheets of p values of individual biological processes, Bonferroni corrected for multiple comparisons.
Results
Induced genes
The complete list of induced and suppressed genes is given in Supplement Tables 1 and 2 . They are too numerous to display in the text. In addition, the raw data values were deposited in the GEO database (GSE41680).
In the first 1e4 hours after the addition of Tyrphostin AG1478, perhaps expectedly it being an inhibitor of EGFR signaling, expression of more genes was suppressed than is induced. Espe cially at the first time point, 1 hour, while many categories were suppressed, only a few ontological categories were induced. These included ubiquitin conjugation enzymes, which lead to protein degradation, and the proapoptotic stimuli (Tables 1 and 2) . A much larger set of ontological categories was induced at the 4 hour time point, but the ubiquitin and in particular the pro apoptosis pathways remain prominent. Many of the induced proteins are targets for acetylation and phosphorylation; this is an unexpected finding and may point to extensive post translational modification in response to EGFR inhibition. Quite unexpectedly, at 4 hours, induction of the genes for melanosome and pigment granule components was observed. Upon closer inspection, these genes encode several organelle constituents and trafficking proteins (Supplement Table 3 ).
After 24 hours of EGFR inhibition a large number of mitochon drial proteins, including oxidoreductases, were induced. Presum ably, at this time the keratinocytes recognize the widespread metabolic downturn. One of the responses to such downturns in metabolism may be to attempt to boost the mitochondrial activity, presumably to produce more energy.
Quite unexpectedly, at the 48 hour time point induction of the keratinocyte specific differentiation markers was observed. Many of these are keratin proteins; others are components of the corni fied envelopes (see below). The induced genes members of the keratin protein family, importantly, include the differentiation specific KRT1 and KRT10, but not the basal layer specific KRT5 and KRT14. These results suggest that in the absence of prolifera tion signals, and with their metabolism suppressed, the keratino cytes revert into a different metabolic mode and commence differentiation and cornification.
Suppressed genes
The number of Tyrphostin AG1478 suppressed categories is much more extensive than of the induced genes (Tables 3 and 4) . Most prominent among these are the positive regulators of metabolic and biosynthetic processes. The positive regulators of cell prolif eration are particularly targeted for suppression. This was predictable, because EGF signals cell proliferation, so the inhibition of EGFR is expected to have an opposite effect. 33 The expression of cell migration associated genes is also suppressed, as is that of focal adhesion and substrate junctional genes. Interestingly, several of the negative regulators of apoptosis are also suppressed by Tyr phostin AG1478. Apparently, the inhibition of EGFR leads to apoptosis by two mechanisms: induction of proapoptotic genes and suppression of antiapoptotic genes. The suppressed ontological categories at 24 hours include the components of membrane bound organelles, including, curiously melanosome (Supplement Table 3 ), as well as nucleotide binding proteins and apoptosis inhibitors (Tables 3 and 4) . Apoptosis is thus advanced both by the induction of proapoptotic, and by suppres sion of the antiapoptotic genes at later time points as well. Inter estingly, after 48 hours, many RNA processing enzymes, splicing factors were suppressed; this follows the general suppression of transcription. Essentially, after 48 hours of blocked signals from EGFR the cells are shutting down, relinquishing all metabolic and biosynthetic processes and attempting to commence differentiation.
The induced differentiation markers
The induction of epidermal differentiation markers in response to EGFR inhibition was particularly intriguing. Components of the cornified envelopes, involucrin, desmoplakin, envoplakin, peri plakin, and periplakin interacting protein, kazrin were induced at the 48 hour time point (Table 5 ). Also induced is the epidermal transglutaminase, the enzyme responsible for crosslinking the cornified envelope proteins. Several small proline rich proteins are also induced, as are certain differentiation specific markers that are not major components of the cornified envelopes, but are essential for the proper cornification, such as kallikrein proteases. Interest ingly, enzymes of lipid metabolism, such as fatty acid binding protein 5 and aldehyde dehydrogenase 3 family, member A2, the gene mutated in Sjögren Larsson syndrome, are also induced at this time.
Regulatory mechanisms involved: transcription factors
The transcriptional changes in response to EGFR inhibition, presumably, reflect the changes in the activity of transcription factors (TFs). Using the DAVID program, the putative TFs respon sible were identified, i.e., those TFs with binding sites statistically over represented in the regulated genes. 30 The most prominent in the suppressed genes are the binding sites for the activator protein (AP1) TF (Table 6 ). This was expected because functional AP1 sites have been found in many marker genes expressed in epidermal keratinocytes. 34 38 AP1 consists of a dimer containing one member of the Fos and one of the Jun family of proteins. 39 The expression of the individual members of the AP1 protein family in different epidermal layers is still controversial. 35, 38, 40 AP1 binds to its consensus palindromic binding site TGA(GC)TCA. 41 The same sequence is recognized by additional TFs, such as NF E2, BACH1 and BACH2. The BACH proteins are basic leucine zipper transcription factors, can function both as transcription activators and as tran scriptional repressors and regulate transcription of genes involved in G1/S and G2/M phases of the cell cycle; they form heterodimers with MafK proteins and are known to be sensitive to oxidative stress. 42, 43 The genes suppressed at early time points additionally contain a statistical overabundance of FOXO1, p53, SRY, cMyb, as well as additional TF binding sites. These TFs may function in the EGFR dependent transcription regulation in epidermal keratinocytes. E74 like factor 3 was also induced (Table 5 ). This epithelia specific Ets transcription factor plays a role in differentiation and may be, in part, responsible for the induction of epidermal differentiation markers noted above.
Fewer TF binding sites reached statistical significance in the induced genes (Table 6 ). This was, of course, expected because much fewer genes are induced than suppressed by the addition of Tyrphostin AG1478 to keratinocyte cultures.
Regulatory mechanisms involved: microRNAs
One of the ways to regulate mRNA levels, besides the activity of TFs, is by microRNAs (miRNAs). 44 To explore the role of miRNAs in response to Tyrphostin AG1478 addition, it was determined which miRNAs target the differentially expressed genes using List2Genes program 32 . While in total 155 miRNAs were analyzed, the targets of only a few miRNAs reached high statis tical relevance (Table 7) . Some of these miRNAs have been implicated in processes related to ones affected by Tyrphostin AG1478, described above. For example, miR 124, miR 26AB, miR 1/206 and miR 320 inhibit proliferation, oncogenesis, metastasis, and epithelial mesenchymal transition. 45 50 All of these processes are activated by EGF and, conversely, inhibited by Tyrphostin AG1478. These results suggest that the inhibitors of the EGFR signaling may act in part through miRNAs in fighting cancers. Targets for miR 19 are also over represented among the sup pressed genes at the early time points, 1 hour and 4 hours. This miRNA was described as a suppressor of inflammation via negative regulation of TLR2, and as exacerbating inflammation by activating NFkB. 51, 52 It is thus unclear whether it plays a role in EGFR signal 32 The matrix, which depicts statistical significance of the overlaps between lists, is presented here in Table 8 . As expected, the genes induced at all four time points created a congruous cate gory, as did the genes suppressed at all four time points. The overlaps were found with extremely high probability, p values reaching 10 À245 and 10 À127 (Table 8) . These congruities are indicated by gray shading. Again as expected, the genes sup pressed by Tyrphostin AG1478 strongly correlate with those induced by EGF and vice versa. This antiparallel, reciprocal relation is highlighted by the opposing directions of arrows, downward versus upward (Table 8) . Similarly, there is a strong parallel relationship between Tyrphostin AG1478 regulated and the SP600125 regulated genes. SP600125 inhibits JNK, one of the activators of Jun, the AP1 family member. However, inhibitors of EGFR can activate JNK in keratinocytes and other cell lines, 53 which would suggest independent pathways for the Tyrphostin AG1478 and SP600125 mediated promotion of differentiation. This issue requires further study.
Comparing lists of Tyrphostin AG1478 regulated genes with those regulated by other signals revealed very interesting patterns: IL 1 and IFNg have 'antiparallel' effects, i.e., generally the processes induced by IL 1 and IFNg are suppressed by Tyr phostin AG1478 and vice versa. This suggests that IL 1 and IFNg activate keratinocytes, similar to EGF, but Tyrphostin AG1478 inhibits keratinocyte activation. Much more complex are the relationships between Tyrphostin AG1478 and TNFa, and Tyr phostin AG1478 and RA. No clear parallel or antiparallel rela tionship can be discerned: certain genes are regulated in common at one time point but others are regulated in opposite directions at other time points (Table 8 ). Particularly intriguing is the comparison with the RA regulated genes: genes induced at 1 hour after RA addition are induced by Tyrphostin AG1478; at later time points RA regulated genes overlap the Tyrphostin AG1478 regulated ones in both the parallel and even more the antipar allel fashion.
Certain genes induced by Tyrphostin AG1478 are also induced by EphrinAs, and the same is true for the suppressed categories (Table 8) . Because EphrinAs induce keratinocyte differentiation markers, 18, 54 which are also induced by Tyrphostin AG1478, the pro differentiation effects of EGFR inhibition parallel those of EphrinA activation.
Discussion
To define comprehensively the molecular effects of inhibiting EGFR in human epidermal keratinocytes we used transcriptional profiling, identified the regulated genes and compared these with genes regulated in keratinocytes by other extracellular signals, and with genes regulated by EGF. Both expected and unexpected classes of regulated genes were found (Fig. 1) . Inhibition of EGFR induces apoptosis, as expected; both the proapoptotic signals are induced and the antiapoptotic ones are suppressed. Numerous genes related to motility and substrate attachment are suppressed by Tyrphostin AG1478. Similarly, the biosynthetic metabolic processes are sup pressed, overall transcription and translation are dampened and various transport processes reduced.
Unexpectedly, the inhibition of EGFR induces expression of keratinocyte differentiation markers. Keratinocyte proliferation and differentiation are mutually incompatible: apparently, inhib iting cell proliferation diverts the cells into a differentiation pathway and consequently certain differentiation markers are induced. These include many of the 'classical' markers, involucrin, keratins KRT1 and KRT10, but also lipid biosynthesis enzymes, lipids being an essential component of the stratum corneum. While both EGF and RA inhibit keratinocyte differentiation, Tyrphostin AG1478 promotes this process. Indeed, we find significant disparity between the effects of Tyrphostin AG1478 and RA: genes induced by one are suppressed by the other and vice versa.
As expected, the effects of EGFR inhibition oppose those invoked by EGF addition. Interestingly, EGFR inhibition also opposes certain of the effects of IL 1 and IFNg. These extracellular signals partici pate in keratinocyte activation, complex and multifaceted responses in wound healing, inflammation and hyperproliferation processes. We are surprised that similar antiparallel relationships were not found between the EGFR inhibition and the TNFa effects. TNFa is one of the best known and most studied activators of keratinocytes, important in psoriasis and other inflammatory diseases. Apparently, different aspects of keratinocyte activation are regulated by EGF, IFNg, IL 1, and TNFa, the well known parallels between IL 1 and TNFa notwithstanding.
Conversely, there are striking parallels with the effects of JNK inhibition: SP600125 and Tyrphostin AG1478 cause similar tran scriptional changes in keratinocytes, in particular, changes associ ated with epidermal differentiation. In a canonical pathway, EGFR activates the ERK signaling cascades. Active ERKs result in activation of, among others, the AP1 transcription factors. JNK is a component of one of the ERK pathways and it also activates AP1. However, inhibitors of EGFR, apparently through unknown, EGFR independent mechanisms, can activate JNK in keratinocytes 53 .
We note that AP1 transcription factor binding sites are significantly over represented among both the Tyrphostin AG1478 suppressed and the SP600125 suppressed genes. Therefore we propose that among the signaling pathways inhibited by Tyrphostin AG1478 are those activating the AP1 proteins.
In conclusion, we present here the transcriptional effects of EGFR inhibition in the epidermis, and compare these with tran scriptional profile changes in the same cell type by different extracellular signaling molecules.
